Yannick Jacques

USPTO Granted Patents = 8 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 91(Granted Patents)

Company Filing History:

6 out of 1,743

Institut National De La Sante Et De La Recherche Medicale

Centre National De La Recherche Scientifique

Inserm (institut National De La Sante Et De La Recherche Medicale)

patents

6. 1 out of 23

Centre Hospitalier Universitaire De Nantes

patents

7. 1 out of 832,812

Other

patents

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12134639 - IL-15Rα sushi domain—IL-15 fusion proteins (2024-11-05),

2. 11008374 - Uses of IL-15 antagonists for the treatment of autoimmune and inflammatory diseases (2021-05-18),

3. 10858452 - Specific interleukin-15 (IL-15) antagonist polypeptide and uses thereof for the treatment of inflammatory and auto-immune diseases (2020-12-08),

4. 10358477 - IL-15Ralpha sushi domain—IL-15 fusion proteins (2019-07-23),

5. 10202433 - IL-15 mutant polypeptides as IL-15 antagonists and encoding nucleic acids (2019-02-12),

6. 9915662 - Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients (2018-03-13),

7. 9493533 - IL-15 mutants having antagonist activity (2016-11-15),

8. 7858081 - IL-15 mutants having agonists/antagonists activity (2010-12-28),

Title: The Innovative Contributions of Yannick Jacques

Introduction

Yannick Jacques is a prominent inventor based in Nantes, France. He has made significant contributions to the field of biomedical research, particularly in the area of interleukin-15 (IL-15) and its applications in treating various diseases. With a total of eight patents to his name, Jacques has established himself as a key figure in his domain.

Latest Patents

Among his latest patents, one notable invention is the IL-15Rα sushi domain—IL-15 fusion proteins. This invention focuses on stimulating the IL-15Rbeta/gamma signaling pathway to induce the activation and proliferation of IL-15Rbeta/gamma-positive cells, such as NK and T cells. The appropriate compounds include those comprising at least one IL-15Rbeta/gamma binding entity, which is covalently linked to a polypeptide containing the sushi domain of the extracellular region of an IL-15Ralpha. Another significant patent involves the use of IL-15 antagonists for the treatment of autoimmune and inflammatory diseases. This invention relates to IL-15 antagonists, particularly an IL-15 mutant polypeptide with specific amino acid substitutions, aimed at addressing autoimmune and inflammatory conditions.

Career Highlights

Yannick Jacques has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the National Center for Scientific Research (Centre National De La Recherche Scientifique). His work at these organizations has allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Throughout his career, Jacques has collaborated with notable colleagues, including Erwan Mortier and Ariane Plet. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Yannick Jacques is a distinguished inventor whose work in the field of interleukin-15 has the potential to impact the treatment of various diseases. His innovative patents and collaborations highlight his commitment to advancing biomedical research.

This text is generated by artificial intelligence and may not be accurate.